All AbMole products are for research use only, cannot be used for human consumption.
TTK21 is an activator of the histone acetyltransferases CBP/p300. TTK21 can cross the blood-brain barrier, and reaches different parts of the brain when conjugated to glucose-based carbon nanosphere (CSP). TTK21 induces acetylation of histones H3 and H4 but not H2B and H2A in vitro.
TTK21 promotes neurogenesis and prolongs memory duration in adult mice, sensory regeneration and germination of motor axons, and recovery of sensory and motor function in mouse and rat models of spinal cord injury. TTK21 has potential for research of brain neurogenesis and long-term memory function.
Molecular Weight | 357.75 |
Formula | C17H15ClF3NO2 |
CAS Number | 709676-56-2 |
Form | Solid |
Solubility (25°C) | DMSO 80 mg/mL (ultrasonic and warming) |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Related Histone Acetyltransferase Products |
---|
CBP/p300-IN-5
P300/CBP-IN-5 is a potent p300/CBP histone acetyltransferase inhibitor, has an IC50 of 18.8 nM. |
JG-2016
JG-2016 is a potent inhibitor of histone acetyltransferase 1 (HAT1), with an IC50 of 14.8 μM in the HAT1 acetylation assays. |
AU-18069
AU-18069 is a CBP/p300 HAT inhibitor that can be used in studies related to hematological and solid tumors. |
KAT modulator-1
KAT modulator-1 is a KAT modulator. |
KAT6-IN-1
KAT6-IN-1 is a potent KAT6 inhibitor. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.